Medico Remedies Limited

BSE:540937 Stock Report

Market Cap: ₹3.4b

Medico Remedies (540937) Stock Overview

Develops, manufactures, and sells pharmaceutical and nutraceutical products in India. More details

540937 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends0/6

540937 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Medico Remedies Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Medico Remedies
Historical stock prices
Current Share Price₹40.67
52 Week High₹79.78
52 Week Low₹36.00
Beta0.053
1 Month Change-16.08%
3 Month Change-30.94%
1 Year Change3.62%
3 Year Change128.35%
5 Year Change1,114.03%
Change since IPO737.26%

Recent News & Updates

Recent updates

Shareholder Returns

540937IN PharmaceuticalsIN Market
7D-2.5%-0.4%-1.0%
1Y3.6%9.1%-2.8%

Return vs Industry: 540937 underperformed the Indian Pharmaceuticals industry which returned 9.1% over the past year.

Return vs Market: 540937 exceeded the Indian Market which returned -2.8% over the past year.

Price Volatility

Is 540937's price volatile compared to industry and market?
540937 volatility
540937 Average Weekly Movement8.4%
Pharmaceuticals Industry Average Movement5.5%
Market Average Movement5.7%
10% most volatile stocks in IN Market8.4%
10% least volatile stocks in IN Market3.9%

Stable Share Price: 540937's share price has been volatile over the past 3 months compared to the Indian market.

Volatility Over Time: 540937's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.

About the Company

FoundedEmployeesCEOWebsite
1994193Harshit Mehtamedicoremedies.com

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and steroidal preparations. It exports its products.

Medico Remedies Limited Fundamentals Summary

How do Medico Remedies's earnings and revenue compare to its market cap?
540937 fundamental statistics
Market cap₹3.38b
Earnings (TTM)₹100.93m
Revenue (TTM)₹1.51b
33.4x
P/E Ratio
2.2x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
540937 income statement (TTM)
Revenue₹1.51b
Cost of Revenue₹1.08b
Gross Profit₹426.11m
Other Expenses₹325.18m
Earnings₹100.93m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)1.22
Gross Margin28.23%
Net Profit Margin6.69%
Debt/Equity Ratio22.1%

How did 540937 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/14 12:50
End of Day Share Price 2025/07/14 00:00
Earnings2025/03/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Medico Remedies Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.